Sacred Leaves Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Sacred Leaves Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $564.1K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sacred Leaves Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $564.1K Trade | TransData Nexus

Sacred Leaves Private Limited

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $564.1K Total Trade · DGFT Verified

Sacred Leaves Private Limited is an Indian pharmaceutical exporter with a total trade value of $564.1K across 4 products in 2 therapeutic categories. Based on 4,879 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Herbal ($457.4K), Velpatasvir ($76.7K), Ledipasvir ($27.3K).

Sacred Leaves Private Limited — Export Portfolio & Destination Treemap

Sacred Leaves Private Limited pharmaceutical export portfolio — 4 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Sacred Leaves Private Limited? — Company Overview & Market Position

Sacred Leaves Private Limited is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established on December 3, 2019, in New Delhi, the company operates under the Corporate Identification Number (CIN) U51909DL2019PTC358299. The authorized share capital is ₹5 million, with a paid-up capital of ₹4.1 million. The registered office is located at Property No. 74, Ground Floor, Gali No. 1, Govindpuri, Kalkaji, New Delhi, Delhi 110019. The company is privately held and unlisted. As of the latest available data, Sacred Leaves Private Limited employs between 11 to 30 people.

What Does Sacred Leaves Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Herbal$457.4K 2Velpatasvir$76.7K

Product Portfolio — Top 4 by Export Value

Sacred Leaves Private Limited exports 4 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Herbal	Ayurvedic & Herbal Products	$457.4K	4,762	2.4%	9
2	Velpatasvir	Antiviral & HIV Medications	$76.7K	38	0.3%	10
3	Ledipasvir	Antiviral & HIV Medications	$27.3K	24	2.4%	4
4	Gutika	Ayurvedic & Herbal Products	$2.7K	55	2.2%	10

Sacred Leaves Private Limited exports 4 pharmaceutical products across 2 therapeutic categories with a total export value of $564.1K. The top category is Ayurvedic & Herbal Products (81.6% of portfolio), followed by Antiviral & HIV Medications (18.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Sacred Leaves Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Sacred Leaves Private Limited operates manufacturing facilities in New Delhi, India. While specific details regarding plant capacities and specializations are not publicly disclosed, the company's focus on finished pharmaceutical formulations suggests that these facilities are equipped to produce a range of dosage forms, including tablets, capsules, syrups, and injections. The facilities are likely designed to adhere to Good Manufacturing Practices (GMP) to ensure product quality and compliance with international standards.

3Key Leadership

The leadership team of Sacred Leaves Private Limited comprises:

Aqueel Ahmad: Director since July 4, 2025.

Sami Ahmad: Director since October 1, 2020.

Shakeel Ahmad: Director since December 3, 2019.

The company's financial performance has shown significant growth, with a 95.84% increase in total revenue for the financial year ending March 31, 2023.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Sacred Leaves Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Sacred Leaves Private Limited's export activities are primarily focused on finished pharmaceutical formulations, including herbal products and antiviral medications. The company's total export value is $564,000 USD, with 4,879 shipments across 4 products in 2 therapeutic categories. The top five products exported are:

Herbal Products: $457,000 USD, ranking #9 with a 2.4% market share.

Velpatasvir: $77,000 USD, ranking #10 with a 0.3% market share.

Ledipasvir: $27,000 USD, ranking #4 with a 2.4% market share.

Gutika: $3,000 USD, ranking #10 with a 2.2% market share.

The primary therapeutic categories are Ayurvedic & Herbal Products (81.6%) and Antiviral & HIV Medications (18.4%). The company's portfolio is highly concentrated, with the top five products accounting for 100% of the export value.

2Emerging Markets

Sacred Leaves Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Sacred Leaves Private Limited's interactions with the U.S. Food and Drug Administration (FDA), including facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history, are not publicly available. The company's export focus on herbal and antiviral products suggests that it may be targeting markets with less stringent regulatory requirements. To enhance its presence in regulated markets like the United States, obtaining FDA approvals and certifications would be advantageous.

2WHO & EU GMP

While specific information regarding WHO prequalification and EU Good Manufacturing Practice (GMP) certifications for Sacred Leaves Private Limited is not publicly disclosed, the company's export activities to various international markets imply adherence to recognized quality standards. Achieving WHO prequalification and EU GMP certification would further validate the company's commitment to quality and facilitate access to additional markets.

3CDSCO & Indian Regulatory

Sacred Leaves Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the Ayurvedic and herbal product segment, Sacred Leaves Private Limited faces competition from established Indian pharmaceutical companies with a global presence. In the antiviral and HIV medication category, the company competes with both multinational corporations and other Indian manufacturers. While specific market share data is not available, the company's export value of $564,000 USD indicates a modest presence in these competitive markets. To enhance its competitive position, the company could consider expanding its product portfolio and strengthening its brand presence.

2Key Differentiators

Sacred Leaves Private Limited's focus on herbal and antiviral products positions it to meet the growing demand for natural and effective healthcare solutions. The company's commitment to quality, as evidenced by its export activities, serves as a competitive advantage. However, the high concentration of export value in a few products suggests that diversifying the product portfolio could further strengthen its market position.

3Strategic Position

Currently, Sacred Leaves Private Limited's strategic direction appears to be focused on exporting herbal and antiviral pharmaceutical formulations. The company's concentration on a limited product range may present challenges in terms of market diversification and risk management. Expanding into generics, specialty drugs, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services could provide new growth avenues. A strategic review to identify and pursue these opportunities would be beneficial for the company's long-term success.

Buyer Due Diligence Brief — Evaluating Sacred Leaves Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Sacred Leaves Private Limited has demonstrated a consistent track record in exporting pharmaceutical formulations, with a total export value of $564,000 USD and 4,879 shipments. The company's focus on herbal and antiviral products indicates a specialization in these therapeutic areas. While specific reliability indicators are not publicly available, the company's active export activities suggest a commitment to meeting international standards and customer expectations.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the company's facility registration with the U.S. Food and Drug Administration.

WHO-GMP Certification: Verify compliance with World Health Organization Good Manufacturing Practices.

EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.

Frequently Asked Questions — Sacred Leaves Private Limited

How many pharmaceutical products does Sacred Leaves Private Limited export from India?

Sacred Leaves Private Limited exports 4 pharmaceutical products across 2 therapeutic categories. The top exports are Herbal ($457.4K), Velpatasvir ($76.7K), Ledipasvir ($27.3K), Gutika ($2.7K). Total export value is $564.1K.

What is Sacred Leaves Private Limited's total pharmaceutical export value?

Sacred Leaves Private Limited's total pharmaceutical export value is $564.1K, based on 4,879 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Sacred Leaves Private Limited cover?

Sacred Leaves Private Limited exports across 2 therapeutic categories. The largest are Ayurvedic & Herbal Products (81.6%, 2 products), Antiviral & HIV Medications (18.4%, 2 products).

Get Full Sacred Leaves Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.